Ganetespib (STA-9090)

For research use only. Not for use in humans.

目录号:S1159

Ganetespib (STA-9090) Chemical Structure

CAS No. 888216-25-9

Ganetespib (STA-9090)是一种HSP90抑制剂,在OSA 8种细胞中IC50为4 nM,诱导OSA细胞凋亡,而不影响正常的成骨细胞;是STA-1474的活性代谢物。Phase 3。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 2472.01 现货
RMB 2187.96 现货
RMB 8763.3 现货
RMB 20229.3 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Ganetespib (STA-9090)发表文献45篇:

产品安全说明书

HSP (HSP90)抑制剂选择性比较

生物活性

产品描述 Ganetespib (STA-9090)是一种HSP90抑制剂,在OSA 8种细胞中IC50为4 nM,诱导OSA细胞凋亡,而不影响正常的成骨细胞;是STA-1474的活性代谢物。Phase 3。
靶点
HSP90 [1]
(OSA 8 cells)
4 nM
体外研究

Ganetespib对恶性肥大细胞系的50%抑制浓度(IC50)比对17-AAG低10-15倍,表明三唑酮类HSP90抑制剂可能比格尔德霉素类抑制剂具有更高的效能。[1] Ganetespib抑制MG63细胞系,IC50为43 nM。[1] Ganetespib结合于Hsp90的N末端ATP结合域,通过引起多重致瘤性Hsp90受体蛋白,包括HER2/neu,突变型EGFR,Akt,c-Kit,IGF-1R,PDGFRα,Jak1,Jak2,STAT3,STAT5,HIF-1α,CDC2和c-Met 以及Wilms' tumor 1的降解,成为一种有效的Hsp90的抑制剂。[2] Ganetespib,在纳摩尔级低浓度下,有效阻滞细胞增殖,并诱导广泛的人肿瘤细胞系凋亡,并且对许多受体酪氨酸激酶抑制剂-和tanespimycin-耐受的细胞系也具有作用。Ganetespib在一系列固体和血液肿瘤细胞系,包括那些对小分子酪氨酸激酶抑制剂耐受的表达突变激酶的细胞系,都表现出有效的细胞毒性。[3] Ganetespib治疗快速引起已知的Hsp90受体蛋白降解,表现出高于ansamycin抑制剂17-AAG的效能,并且在较短的暴露时间下也具有持续的活性。[3]在另一个研究中,Ganetespib诱导恶性犬肥大细胞系凋亡。Ganetespib在非常低的浓度下,有效作用于C2和BR犬恶性肥大细胞,IC50分别为19和4 nM,而17-AAG抑制C2和BR犬恶性肥大细胞的IC50分别为958和44 nM。[4]100 nM Ganetespib处理24小时后,所有处理过的细胞系,包括C2和BMCMCs细胞中WT和突变型Kit的表达被下调。然而,Ganetespib处理后不影响PI3K或HSP90的表达。[4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
NCI-H1975 NHPNT2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVLVWno4PzJiaB?= NYfKZ4F6UUN3ME24JI5O NHXVT5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkG0OFY3PSd-MkKxOFQ3PjV:L3G+
NCI-H1975 NWrSRZhCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVG0PEBp M33Zd2lEPTB;MU[gcm0> M1nLPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUS0OlY2Lz5{MkG0OFY3PTxxYU6=
Calu-6 MmrlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH\4UXZKSzVyPU[0JI5O M17FUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEGyNlQ5Lz5{M{CxNlI1QDxxYU6=
Calu-1 NXPqPIloT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIDMZ3BKSzVyPUW4JI5O Ml3iQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUKyOFgoRjJ|MEGyNlQ5RC:jPh?=
H2122 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnK5TWM2OD13MzDuUS=> NWHUcYtpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNVIzPDhpPkKzNFEzOjR6PD;hQi=>
A549 NWTE[pV4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{Dxb2lEPTB;NEOgcm0> NF7PS2Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{CxNlI1QCd-MkOwNVIzPDh:L3G+
H358 M125UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFfOOmlKSzVyPUK5JI5O MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzBzMkK0PEc,OjNyMUKyOFg9N2F-
H1734 M3HmNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjVeZVKSzVyPUK4JI5O NHLaNJQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{CxNlI1QCd-MkOwNVIzPDh:L3G+
H727 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2j3ZmlEPTB;Mkigcm0> NX7mRYVGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNVIzPDhpPkKzNFEzOjR6PD;hQi=>
COR-L23 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWTJR|UxRTJ{IH7N NVPmNpF3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNVIzPDhpPkKzNFEzOjR6PD;hQi=>
H1792 M2\meWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYL0XnN4UUN3ME2yNEBvVQ>? NFHvSY49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{CxNlI1QCd-MkOwNVIzPDh:L3G+
H2009 Ml3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTF7IH7N M1zyWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEGyNlQ5Lz5{M{CxNlI1QDxxYU6=
SK-LU-1 NEfoNFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWXJR|UxRTF6IH7N NVTySZRqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNVIzPDhpPkKzNFEzOjR6PD;hQi=>
H2212 NFzTUZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXO2VYJ[UUN3ME2xO{BvVQ>? MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzBzMkK0PEc,OjNyMUKyOFg9N2F-
H441 NHi5ZoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXjTXnlPUUN3ME2xOEBvVQ>? NX64NHdsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNVIzPDhpPkKzNFEzOjR6PD;hQi=>
H2030 NHv6eWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHXiNIRKSzVyPUGyJI5O M4\jT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEGyNlQ5Lz5{M{CxNlI1QDxxYU6=
H23 NVrpWJpCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGq0PVBKSzVyPUGxJI5O Ml3hQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUKyOFgoRjJ|MEGyNlQ5RC:jPh?=
HOP-62 M2nyUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXPCdIxjUUN3ME2xNUBvVQ>? MlX2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUKyOFgoRjJ|MEGyNlQ5RC:jPh?=
IA-LM NY[0PXJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTFyIH7N Ml\nQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUKyOFgoRjJ|MEGyNlQ5RC:jPh?=
H460 NXvuc4FIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV:yTY9oUUN3ME24JI5O MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzBzMkK0PEc,OjNyMUKyOFg9N2F-
H157 Mmm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnYSHhKSzVyPUegcm0> Ml\tQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUKyOFgoRjJ|MEGyNlQ5RC:jPh?=
H1355 Mme0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3rWeGlEPTB;NTDuUS=> MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzBzMkK0PEc,OjNyMUKyOFg9N2F-
VCaP NVL0N215T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1zK[mlEPTB;NzDuUS=> MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF3MkCwOEc,OjNzNUKwNFQ9N2F-
LNCaP MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXXqe4xVUUN3ME24JI5O M2XEd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MUWyNFA1Lz5{M{G1NlAxPDxxYU6=
Ramos-RA1 NFfKZnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4fye2lEPTB;Nz60JI5O MoTUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|MEO3OFEoRjJ|M{CzO|QyRC:jPh?=
Karpas-299 M{L1cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4PzTGlEPTB;OT62JI5O MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNyM{e0NUc,OjN|MEO3OFE9N2F-
Kasumi-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M376VGlEPTB;NT64JI5O MnPJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|MEO3OFEoRjJ|M{CzO|QyRC:jPh?=
CCRF-CEM (2) NFfDNWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH7wTFZKSzVyPUeuNkBvVQ>? NYDXNIhtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNFM4PDFpPkKzN|A{PzRzPD;hQi=>
CCRF-CEM (1) Ml:wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYPlXXh3UUN3ME2xNk42KG6P NUjLNoh2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNFM4PDFpPkKzN|A{PzRzPD;hQi=>
MOLT-4 NHTNT41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIC4U25KSzVyPUGwMlYhdk1? MmjuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|MEO3OFEoRjJ|M{CzO|QyRC:jPh?=
RS4;11 NESwSFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;6TGlEPTB;MUOuOUBvVQ>? NU\KZpdmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNFM4PDFpPkKzN|A{PzRzPD;hQi=>
COG-LL-317 M2TETGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXvJR|UxRTRwNDDuUS=> M4GzNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{CzO|QyLz5{M{OwN|c1OTxxYU6=
NALM-6 M3jFe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LTcmlEPTB;MUGuO{BvVQ>? NV;LOlRERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNFM4PDFpPkKzN|A{PzRzPD;hQi=>
CHLA-136 Mnj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M160RWlEPTB;MkOuNkBvVQ>? NV\BSlFjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNFM4PDFpPkKzN|A{PzRzPD;hQi=>
CHLA-90 M3LL[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUDrZnZQUUN3ME2yNk4{KG6P NH3RWHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OwN|c1OSd-MkOzNFM4PDF:L3G+
NB-EBc1 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn\DTWM2OD1zNj64JI5O MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNyM{e0NUc,OjN|MEO3OFE9N2F-
NB-1643 Mk\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NULkPIJPUUN3ME23MlQhdk1? MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNyM{e0NUc,OjN|MEO3OFE9N2F-
SJ-GBM2 MkDmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXjoSlQ1UUN3ME2xNk46KG6P MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNyM{e0NUc,OjN|MEO3OFE9N2F-
CHLA-258 Mmq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV[2UHlXUUN3ME22MlQhdk1? NIixOm09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OwN|c1OSd-MkOzNFM4PDF:L3G+
CHLA-10 M3XF[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M17KXmlEPTB;NT63JI5O NF7jNpM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OwN|c1OSd-MkOzNFM4PDF:L3G+
CHLA-9 NV7TWIlCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmLmTWM2OD12Lk[gcm0> MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNyM{e0NUc,OjN|MEO3OFE9N2F-
TC-71 M1XZfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTRwNTDuUS=> M2XvXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{CzO|QyLz5{M{OwN|c1OTxxYU6=
CHLA-266 M{DQNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFO2SmhKSzVyPUK3MlEhdk1? MnLxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|MEO3OFEoRjJ|M{CzO|QyRC:jPh?=
BT-12 M2PxOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jFSGlEPTB;MUSuN{BvVQ>? M1ixTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{CzO|QyLz5{M{OwN|c1OTxxYU6=
Rh30 M2f5Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnVTWM2OD13Lk[gcm0> NI\ufIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OwN|c1OSd-MkOzNFM4PDF:L3G+
Rh18 M1XoSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2PaeGlEPTB;Nj6yJI5O NWP6RpR6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNFM4PDFpPkKzN|A{PzRzPD;hQi=>
Rh41 NEXGUYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorpTWM2OD1zMD60JI5O MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNyM{e0NUc,OjN|MEO3OFE9N2F-
RD M4npbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjpdZZKSzVyPUigcm0> NGrVeHc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OwN|c1OSd-MkOzNFM4PDF:L3G+
K033 M4HYe2Fxd3C2b4Ppd{BCe3OjeR?= NYPxXItPOTByIH7N NH7nXmI4OiCq Mlrwd4lodmmoaXPhcpRtgSCrbnT1Z4V{KGGyb4D0c5Nqew>? M4DyRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NEG4OVI{Lz5{M{SxPFUzOzxxYU6=
M23 MmPURZBweHSxc3nzJGF{e2G7 NGTWdIEyODBibl2= M2PR[lczKGh? NIDFUpJ{cWewaX\pZ4FvfGy7IHnu[JVk\XNiYYDvdJRwe2m| MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRzOEWyN{c,OjN2MUi1NlM9N2F-
K029 M1LL[WFxd3C2b4Ppd{BCe3OjeR?= M{ftO|ExOCCwTR?= M3vvT|czKGh? M1TWR5Nq\26rZnnjZY51dHliaX7keYNmeyCjcH;weI9{cXN? NHq5Xlc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SxPFUzOyd-MkO0NVg2OjN:L3G+
K028 MXjBdI9xfG:|aYOgRZN{[Xl? Mnn5NVAxKG6P M2[0cFczKGh? NH7Lc|B{cWewaX\pZ4FvfGy7IHnu[JVk\XNiYYDvdJRwe2m| MlLVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MUi1NlMoRjJ|NEG4OVI{RC:jPh?=
K008 MmDPRZBweHSxc3nzJGF{e2G7 NIj3fYoyODBibl2= M{LPOVczKGh? M2XaPZNq\26rZnnjZY51dHliaX7keYNmeyCjcH;weI9{cXN? Mm\kQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MUi1NlMoRjJ|NEG4OVI{RC:jPh?=
K033 M{LwdmZ2dmO2aX;uJGF{e2G7 MWOyOVAhdk1? NU\EZVM1OjRiaB?= M3fMdIlv\HWlZYOgZUBud2Snc4SgbY5kemWjc3WgbY4hTzFicH;weYxifGmxbh?= MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRzOEWyN{c,OjN2MUi1NlM9N2F-
M23 MYDGeY5kfGmxbjDBd5NigQ>? M33j[lI2OCCwTR?= MmHCNlQhcA>? NFPXPGJqdmS3Y3XzJGcyKGGwZDDHNk9OKGG{cnXzeC=> NIi3epQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SxPFUzOyd-MkO0NVg2OjN:L3G+
K029 M1\oVGZ2dmO2aX;uJGF{e2G7 MljlNlUxKG6P Mk\TNlQhcA>? MkLwbY5lfWOnczDHNUBienKnc4S= NY\DSpN4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0NVg2OjNpPkKzOFE5PTJ|PD;hQi=>
K028 NWi1RXcyTnWwY4Tpc44hSXO|YYm= Mnr6NlUxKG6P M3vJblI1KGh? M3O2SIlv\HWlZYOgS|Ih[XK{ZYP0 MmraQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MUi1NlMoRjJ|NEG4OVI{RC:jPh?=
K008 Mn;ySpVv[3Srb36gRZN{[Xl? MYWyOVAhdk1? MoHqNlQhcA>? M2jWV4lv\HWlZYOgS|Ih[XK{ZYP0 MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRzOEWyN{c,OjN2MUi1NlM9N2F-
K033 NYrpZ443S2WubDDWbYFjcWyrdImgRZN{[Xl? Mm\vTWM2OD15NT61JI5O MlW0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MUi1NlMoRjJ|NEG4OVI{RC:jPh?=
M23 NXy3ZnJ3S2WubDDWbYFjcWyrdImgRZN{[Xl? MULJR|UxRTN5LkWgcm0> MlG1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MUi1NlMoRjJ|NEG4OVI{RC:jPh?=
K029 NVzsVlg6S2WubDDWbYFjcWyrdImgRZN{[Xl? M{LHNmlEPTB;NE[gcm0> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRzOEWyN{c,OjN2MUi1NlM9N2F-
K028 MnjGR4VtdCCYaXHibYxqfHliQYPzZZk> MofoTWM2OD16NDDuUS=> NIf1RZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SxPFUzOyd-MkO0NVg2OjN:L3G+
K008 M1y3SWNmdGxiVnnhZoltcXS7IFHzd4F6 NETXclJKSzVyPU[wJI5O MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRzOEWyN{c,OjN2MUi1NlM9N2F-
H3122 MUnD[YxtKF[rYXLpcIl1gSCDc4PhfS=> NYLHVFJZOC1zMECwJI5O MVu3NkBp NIPMUXpKSzVyPUGwJI5O MkjXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{OyOlUoRjJ|NUOzNlY2RC:jPh?=
H2228 NVLYfYozS2WubDDWbYFjcWyrdImgRZN{[Xl? MV[wMVExODBibl2= MXW3NkBp M3XmOmlEPTB;MUOgcm0> NFvVdpY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzN|I3PSd-MkO1N|MzPjV:L3G+
A1847 NFzzWolCeG:ydH;zbZMhSXO|YYm= MYqxNE0yODBibl2= MoLINlQwPDhxN{KgbC=> MmHMbY5lfWOnczDhdI9xfG:|aYOgeIlu\SCjbnSg[I9{\SCmZYDlcoRmdnSueR?= NXfpdYJ[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5NFAyOzZpPkKzPVAxOTN4PD;hQi=>
OVCAR-8 MY\BdI9xfG:|aYOgRZN{[Xl? M{L6VFExNTFyMDDuUS=> NHHJSGozPC92OD:3NkBp MlXvbY5lfWOnczDhdI9xfG:|aYOgeIlu\SCjbnSg[I9{\SCmZYDlcoRmdnSueR?= M{PEelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|OUCwNVM3Lz5{M{mwNFE{PjxxYU6=
OVCAR-5 M3nLWmFxd3C2b4Ppd{BCe3OjeR?= NGD6U4IyOC1zMECgcm0> MnG5NlQwPDhxN{KgbC=> MYjpcoR2[2W|IHHwc5B1d3OrczD0bY1mKGGwZDDkc5NmKGSncHXu[IVvfGy7 NGWzWFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mwNFE{Pid-MkO5NFAyOzZ:L3G+
SKOV-3 NF;CTHVE\WyuIG\pZYJqdGm2eTDBd5NigQ>? MkXtNE0yODByIH7N Moe1O|IhcA>? M2WxPYlvcGmkaYTzJINmdGxidnnhZoltcXS7IHTvd4Uh\GWyZX7k[Y51dHl? MlyzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7MECxN|YoRjJ|OUCwNVM3RC:jPh?=
A1847 MWTD[YxtKF[rYXLpcIl1gSCDc4PhfS=> NH3VfHcxNTFyMECgcm0> Mk\IO|IhcA>? NXjn[ZZQcW6qaXLpeJMh[2WubDD2bYFjcWyrdImg[I9{\SCmZYDlcoRmdnSueR?= MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzlyMEGzOkc,OjN7MECxN|Y9N2F-
OVCAR-8 NFf2OmpE\WyuIG\pZYJqdGm2eTDBd5NigQ>? NV;TNI9UOC1zMECwJI5O NXnKXHhxPzJiaB?= MUTpcohq[mm2czDj[YxtKH[rYXLpcIl1gSCmb4PlJIRmeGWwZHXueIx6 MnjsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7MECxN|YoRjJ|OUCwNVM3RC:jPh?=
OVCAR-5 M2rZemNmdGxiVnnhZoltcXS7IFHzd4F6 NGPRUIIxNTFyMECgcm0> MlmwO|IhcA>? MYLpcohq[mm2czDj[YxtKH[rYXLpcIl1gSCmb4PlJIRmeGWwZHXueIx6 NHG1VZc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mwNFE{Pid-MkO5NFAyOzZ:L3G+
H146  NVrPcmFwTnWwY4Tpc44hSXO|YYm= Mn2zN|Ahdk1? Mn;0O|IhcA>? MV3pcoR2[2W|IIDldpNqe3SnboSgS|IwVSCyaHHz[UBienKnc4S= NI\pcmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG2OlUxPSd-MkSxOlY2ODV:L3G+
GLC4 M2DCcmZ2dmO2aX;uJGF{e2G7 Mk\RN|Ahdk1? NF;wNYo4OiCq Mnj0bY5lfWOnczDw[ZJ{cXO2ZX70JGczN01icHjhd4Uh[XK{ZYP0 Mlz0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNk[1NFUoRjJ2MU[2OVA2RC:jPh?=
H82 M4PPdmZ2dmO2aX;uJGF{e2G7 NIrrflQ{OCCwTR?= MVK3NkBp M3uxXYlv\HWlZYOgdIVze2m|dHXueEBIOi:PIIDoZZNmKGG{cnXzeC=> MmPpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNk[1NFUoRjJ2MU[2OVA2RC:jPh?=
AC3 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXYV3lKSzVyPUK1Mlkhdk1? NXfyc3NvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOlY2ODVpPkK0NVY3PTB3PD;hQi=>
H1173 M13zN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4HZUGlEPTB;MUKuOlIhdk1? NGD2Ro49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG2OlUxPSd-MkSxOlY2ODV:L3G+
H792 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYSxe4F{UUN3ME20OU4xPyCwTR?= NH32eoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG2OlUxPSd-MkSxOlY2ODV:L3G+
H620 NFPsXVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGDjVXBKSzVyPUOyMlY4KG6P MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF4NkWwOUc,OjRzNk[1NFU9N2F-
N592 MkPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWTIXGhYUUN3ME2xOE4yOiCwTR?= M3GyTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MU[2OVA2Lz5{NEG2OlUxPTxxYU6=
H526 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVHTd5dYUUN3ME2yNU43PCCwTR?= M4fvXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MU[2OVA2Lz5{NEG2OlUxPTxxYU6=
H187 M{TmS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXqTWM2OD1{ND65PUBvVQ>? Mk\3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNk[1NFUoRjJ2MU[2OVA2RC:jPh?=
H146 M1rMNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LHTmlEPTB;MkiuOVEhdk1? NGP4Tow9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG2OlUxPSd-MkSxOlY2ODV:L3G+
H128 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnnHTWM2OD14OT61OUBvVQ>? MmjGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNk[1NFUoRjJ2MU[2OVA2RC:jPh?=
H69 M{LucGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlywTWM2OD16Mz6zOkBvVQ>? MnvFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNk[1NFUoRjJ2MU[2OVA2RC:jPh?=
GLC4 NHTadm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4joe2lEPTB;MkCuOFchdk1? M2mye|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MU[2OVA2Lz5{NEG2OlUxPTxxYU6=
H82 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoG2TWM2OD1|MD6yO{BvVQ>? NF7xS449[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG2OlUxPSd-MkSxOlY2ODV:L3G+
MDA-MB-231 NVfjXIJsTnWwY4Tpc44hSXO|YYm= MWexNFAhdk1? NVnTPJJKOjRiaB?= Moj4bY5pcWKrdIOgeIhmKG2rZ4LheI9zgSCjbnSgbY53[XOrdnWgZ4Fx[WOrdIpCpC=> M{\zVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUezOVQyLz5{NEG3N|U1OTxxYU6=
BT-20  M2frXWZ2dmO2aX;uJGF{e2G7 MljqNVAxNzJ3MDDuUS=> NFzCPI8zPCCq MoLKdoV{fWy2ZXSgbY4h[SCmb4PlMYRmeGWwZHXueEBl\XO2YXLpcIl7[XSrb36gc4YhTUeIUjygTWdHNUmULDDNSXQtKGGwZDDDVmFH MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF5M{W0NUc,OjRzN{O1OFE9N2F-
MDA-MB-435 M2LCXmZ2dmO2aX;uJGF{e2G7 MVKxNFAhdk1? NEHkfG4{OCCvaX6= MYLpcohq[mm2czDhZ4N2dXWuYYTpc44hd2ZiSFnGMVHPuQ>? NW\TUJc1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSyOFgzPjVpPkK0NlQ5OjZ3PD;hQi=>
MDA-MB-231 Mn:1SpVv[3Srb36gRZN{[Xl? MXSxNFAhdk1? MmT0N|AhdWmw NYm2WZVHcW6qaXLpeJMh[WOldX31cIF1cW:wIH;mJGhKTi1zzsG= NHzIflA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEK0PFI3PSd-MkSyOFgzPjV:L3G+
HCC2998 M2nMb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWnJR|UxRTF{ODDuUS=> MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6Mke0O{c,OjR4OEK3OFc9N2F-
SK-CO-1 Mm\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIPXfJlKSzVyPUixJI5O MoPaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4OEK3OFcoRjJ2NkiyO|Q4RC:jPh?=
LS-123 M1Lue2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37ydGlEPTB;N{Ogcm0> MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6Mke0O{c,OjR4OEK3OFc9N2F-
SNU-C2B NHfiV3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mm[5TWM2OD12NTDuUS=> NVnPdmFERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2PFI4PDdpPkK0OlgzPzR5PD;hQi=>
LS-1034 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEPFfllKSzVyPUOxJI5O M3;aeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NkiyO|Q4Lz5{NE[4Nlc1PzxxYU6=
LoVo M3zoOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFqwelVKSzVyPUKyJI5O NYX6S4NqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2PFI4PDdpPkK0OlgzPzR5PD;hQi=>
COLO-678 Mk\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnK[pgzUUN3ME2yNUBvVQ>? MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6Mke0O{c,OjR4OEK3OFc9N2F-
NCI-H747 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4[wPGlEPTB;MUegcm0> NIfh[5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4Nlc1Pyd-MkS2PFI4PDd:L3G+
COLO-205 MnTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEjFUnRKSzVyPUG0JI5O NWHTSGh1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2PFI4PDdpPkK0OlgzPzR5PD;hQi=>
HCT 116 NVTvVmM1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPBNmdKUUN3ME2xOEBvVQ>? Mnm1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4OEK3OFcoRjJ2NkiyO|Q4RC:jPh?=
HuTu-80 M3zhOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUD2eVAyUUN3ME2xN{BvVQ>? NELPR409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4Nlc1Pyd-MkS2PFI4PDd:L3G+
HCT-15 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\GRmNKSzVyPUigcm0> NHrLSlA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4Nlc1Pyd-MkS2PFI4PDd:L3G+
SW620 M{[3fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUjJR|UxRThibl2= NInFSIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4Nlc1Pyd-MkS2PFI4PDd:L3G+
LS-411 N MofXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWHJR|UxRTVibl2= NELtN|Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4Nlc1Pyd-MkS2PFI4PDd:L3G+
RKO NYTiS2pGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYD0d296UUN3ME20JI5O NWrCfGZrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2PFI4PDdpPkK0OlgzPzR5PD;hQi=>
SW780 M{eyUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUPTSHl2UUN3ME2zOFUyKG6P NF;tbmo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe4OFg{QSd-MkS3PFQ5Ozl:L3G+
RT4 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX\JR|UxRTF5M{Ogcm0> NYqxVXVyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PFQ5OzlpPkK0O|g1QDN7PD;hQi=>
TCCSUP NX;wZXRRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWLSXWNjUUN3ME2xOFIhdk1? Mnf0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5OES4N|koRjJ2N{i0PFM6RC:jPh?=
MGH-U3 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfXcFN6UUN3ME21N{BvVQ>? NXm3TY9TRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PFQ5OzlpPkK0O|g1QDN7PD;hQi=>
HT-1197 NFrNUoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHnXW4dKSzVyPUWzJI5O NEHvNnI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe4OFg{QSd-MkS3PFQ5Ozl:L3G+
5637 NEDicFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4nONWlEPTB;NESgcm0> NYPjO2k3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PFQ5OzlpPkK0O|g1QDN7PD;hQi=>
35612 NF\4PHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{nIXGlEPTB;M{igcm0> NVfMe5FHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PFQ5OzlpPkK0O|g1QDN7PD;hQi=>
KU-19-19 MmnqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTN4IH7N M3m1VVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{i0PFM6Lz5{NEe4OFg{QTxxYU6=
LB831-BLC MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnCUWhwUUN3ME2zOEBvVQ>? Mn34QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5OES4N|koRjJ2N{i0PFM6RC:jPh?=
UM-UC3 NX7wbotKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3ricWlEPTB;M{Ogcm0> M{LxRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{i0PFM6Lz5{NEe4OFg{QTxxYU6=
647-V M2n0SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX7lcGM1UUN3ME2yO{BvVQ>? MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd6NEizPUc,OjR5OES4N|k9N2F-
HT-1376 MnLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWHJR|UxRTJzIH7N M{fWTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{i0PFM6Lz5{NEe4OFg{QTxxYU6=
J82 Mk\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXfqXZNWUUN3ME2xPEBvVQ>? MlHtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5OES4N|koRjJ2N{i0PFM6RC:jPh?=
BFTC MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFfrdGpKSzVyPUG3JI5O MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd6NEizPUc,OjR5OES4N|k9N2F-
SCaBER NVL5foxzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHL2PXBKSzVyPUGwJI5O Mm[xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5OES4N|koRjJ2N{i0PFM6RC:jPh?=
639-V NIn2NpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIi5cFlKSzVyPUGwJI5O MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd6NEizPUc,OjR5OES4N|k9N2F-
RT112 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYG4b4xbUUN3ME25JI5O MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd6NEizPUc,OjR5OES4N|k9N2F-
T24 NU[2SYU2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml24TWM2OD15IH7N NX22dIF[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PFQ5OzlpPkK0O|g1QDN7PD;hQi=>
SW-1710 NI\qVmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV;JR|UxRTZibl2= NX3ofIFTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3PFQ5OzlpPkK0O|g1QDN7PD;hQi=>
DSH1 MmCxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlq0TWM2OD14IH7N M1HX[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{i0PFM6Lz5{NEe4OFg{QTxxYU6=
CAL27 M1jkXWN6fG:6aXPpeJkhSXO|YYm= MUGxNE82OCCwTR?= MoLUNlQhcA>? NVjLeFdk\GWlcnXhd4V{KGOnbHygdJJwdGmoZYLheIlwdiCmb4PlJIRmeGWwZHXueIx6 MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTJyNUSzNEc,OjV{MEW0N|A9N2F-
Detroit562 Mnf6R5l1d3irY3n0fUBCe3OjeR?= MlfPNVAwPTBibl2= M2\xcVI1KGh? MYDk[YNz\WG|ZYOgZ4VtdCCycn;sbYZmemG2aX;uJIRwe2ViZHXw[Y5l\W62bIm= M4XtVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MkC1OFMxLz5{NUKwOVQ{ODxxYU6=
FUDA NITqWJdEgXSxeHnjbZR6KEG|c3H5 NFvud40yOC93MDDuUS=> MUWyOEBp NH;QUHNl\WO{ZXHz[ZMh[2WubDDwdo9tcW[ncnH0bY9vKGSxc3Wg[IVx\W6mZX70cJk> NFz4RYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUKwOVQ{OCd-MkWyNFU1OzB:L3G+
SCC25 M1nHPWN6fG:6aXPpeJkhSXO|YYm= MofYNVAwPTBibl2= NU\jb|R7OjRiaB?= M3LLSYRm[3KnYYPld{Bk\WyuIIDyc4xq\mW{YYTpc44h\G:|ZTDk[ZBmdmSnboTsfS=> MlfMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{MEW0N|AoRjJ3MkC1OFMxRC:jPh?=
HT-29 MkH5SpVv[3Srb36gRZN{[Xl? MVm1NI5O NVjGV2xsOjRiaB?= MVXEUXNQ M4DicIlv\HWlZXSgS|AwTzFiYYLy[ZN1 NGTrRnQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUKxNFc6PCd-MkWyNVA4QTR:L3G+
HCT-116 NGjGb3hHfW6ldHnvckBCe3OjeR?= MnLGOVBvVQ>? NUfTb3pIOjRiaB?= NWK2b3lMTE2VTx?= NIf3T2dqdmS3Y3XkJGcxN0dzIHHydoV{fA>? NYLKVlJMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyNVA4QTRpPkK1NlExPzl2PD;hQi=>
MGC-803 NEK0c3pHfW6ldHnvckBCe3OjeR?= MWKwMlEuOTByMDDuUS=> M2nzZlI1KGh? MUPpcoR2[2W|IFeyM20h[2WubD3jfYNt\SCjcoLld5Q> NG\VN3A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUW5NFgxPSd-MkW1PVA5ODV:L3G+
MKN-28 NFixfIRE\WyuIG\pZYJqdGm2eTDBd5NigQ>? MoftNE4yNTFyMECgcm0> M3Xn[VczKGh? M4O4SYlvcGmkaYTzJINmdGxidnnhZoltcXS7IHTvd4Uh\GWyZX7k[Y51dHl? M1rSbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NUmwPFA2Lz5{NUW5NFgxPTxxYU6=
SGC-7901 NY[xWnhNS2WubDDWbYFjcWyrdImgRZN{[Xl? MYWwMlEuOTByMDDuUS=> MWi3NkBp NGrKTmVqdmirYnn0d{Bk\WyuII\pZYJqdGm2eTDkc5NmKGSncHXu[IVvfGy7 NEHRR|A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUW5NFgxPSd-MkW1PVA5ODV:L3G+
MGC-803 MlrGR4VtdCCYaXHibYxqfHliQYPzZZk> M2Pa[lAvOS1zMECwJI5O MlrqO|IhcA>? MmfBbY5pcWKrdIOgZ4VtdCC4aXHibYxqfHliZH;z[UBl\XCnbnTlcpRtgQ>? M4\5RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NUmwPFA2Lz5{NUW5NFgxPTxxYU6=
MV411 MVnBdI9xfG:|aYOgRZN{[Xl? M{PqeFMxNzhyL{G1NE8zPTBibl2= MnnkNlQwPDhxN{KgbC=> MVnpcoR2[2W|IHTvd4Uh\GWyZX7kZY51KGmwZIXjeIlwdiCxZjDhdI9xfG:|aYO= MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh6MkW1NEc,OjV6OEK1OVA9N2F-
HL60 NILO[HNCeG:ydH;zbZMhSXO|YYm= NX3reXVCOzBxOECvNVUxNzJ3MDDuUS=> MkLXNlQwPDhxN{KgbC=> MUDpcoR2[2W|IHTvd4Uh\GWyZX7kZY51KGmwZIXjeIlwdiCxZjDhdI9xfG:|aYO= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh6MkW1NEc,OjV6OEK1OVA9N2F-
TC32 MYXxTHRUKGG|c3H5 NIWzdppyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiVFOzNkBk\Wyucx?= NETITpY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
A673 MY\xTHRUKGG|c3H5 MkPsdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? MoH6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
Saos-2 Ml3idWhVWyCjc4PhfS=> NYLWUWRGeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPhc5MuOiClZXzsdy=> NX3CU5ZwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 MYPxTHRUKGG|c3H5 M2\4WZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCEVD2zO{Bk\Wyucx?= NUPab3VsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
RD M1TKOZFJXFNiYYPzZZk> MlfxdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{ NIG4UXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-SH NWnTdnZTeUiWUzDhd5NigQ>? NVP3cpJueUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uW0hiY3XscJM> NVHSNXlKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB1643 Ml7adWhVWyCjc4PhfS=> MX7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVkJzNkSzJINmdGy| M{S0c|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
OHS-50 NX\TXXFmeUiWUzDhd5NigQ>? NGSwcZNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiT1jTMVUxKGOnbHzz MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
A673 M{XRZ5FJXFNiYYPzZZk> NXHVWWl[eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhSTZ5MzDj[Yxteyl? M1zyTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SJ-GBM2 MXzxTHRUKGG|c3H5 MULxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?= M1zEWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-MC MlH2dWhVWyCjc4PhfS=> MULxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= NHjteZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB-EBc1 MXzxTHRUKGG|c3H5 NWDqbFBVeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CMWVD[zFiY3XscJM> MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
LAN-5 MXXxTHRUKGG|c3H5 NFjMZZByUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTFHOMVUh[2WubIO= NYjifWFZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18 NVfJTYxKeUiWUzDhd5NigQ>? MYrxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmhzODDj[Yxtew>? M3n3NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
EGFR / c-Met / IGF-1Rβ/ Akt / p-Akt / ERK / p-ERK; 

PubMed: 23418523     


Downregulation of multiple signaling pathways by ganetespib in melanoma cells.A. Cells were treated with indicated amounts of ganetespib for 24 h. B-RAF and N-RAS mutational status of each cell line is indicated.

p27(Kip1) / p21 (Cip1) / Cyclin D1 / Cyclin E / Cyclin B1 / CDK1 / CDK2 / CDK4; 

PubMed: 23418523     


Alterations in expression of multiple cell cycle regulating proteins induced by ganetespib. Cells were treated with indicated amounts of ganetespib for 48 h and analyzed by Western blot analysis. Relative expression levels of proteins (treated vs. control䲧疝Ỵ疞㧀疜膉痘 

Survivin / Bcl-2 / Bcl-xl / Mcl-1; 

PubMed: 23418523     


Effect of ganetespib on the expression of antiapoptotic proteins. Cells were treated with ganetespib for 48 h and analyzed using Western blot analysis. Relative expression levels of proteins are indicated.

B-RAF / C-RAF / N-RAS ; 

PubMed: 23418523     


Effect of ganetespib on B-RAF, C-RAF and N-RAS expression in melanoma cells.Cells were treated with indicated amounts of ganetespib for 48 h and subjected to Western blot analysis.

HER2 / p-STAT3 / BIM ; 

PubMed: 25077897     


NCI-H1975 cells were incubated with the indicated concentrations of ganetespib for 24 h. Cell lysates were analyzed by Western blotting.

CDK1 / Cyclin D1 / Cyclin B1 / p27; 

PubMed: 29717218     


Cropped Western blot images of the indicated cell cycle regulators are shown in ganetespib-treated (0–300 nM for 16 hours) BT474 and SKBR3 cells. 

c-PARP / c-caspase 3 / caspase 8 / c-caspase 8 / caspase 9 / c-caspase 9; 

PubMed: 29717218     


Cropped images of Western blots at the target molecular weights for the indicated apoptotic markers are shown in ganetespib-treated (0, 10, 30, 100, 300 nM for 16 hours) BT474 and SKBR3 cells. 

ErbB2 / pErbB2 / Src / pSrc / mTOR / pmTOR / Bad / pBad / GSK3 / pGSK3; 

PubMed: 29717218     


Ganetespib inhibits RTK signaling in ErbB2+ breast cancer cells. BT474 and SKBR3 cells were treated with ganetespib (0, 10, 30, 100, or 300 nM) for 16 hours, followed by Western blot analysis (cropped images) of the expression and activation/phosphorylati䲧疝Ỵ疞㧀疜膉痘 瘿뙠ෆᾰƌෆĀ 㺣痖帉痖

Wee1 / p-Wee1 / Chk1 / p-Chk1; 

PubMed: 27834954     


Hsp90 inhibition degrades the G2/M checkpoint kinases Wee1 and Chk1. The cells were treated with 200 nM ganetespib and 75 μM carboplatin for 24 h followed by immunoblot analysis. Carboplatin treatment leads to the activation of Chk1, indicated by phospho—䲧疝Ỵ疞㧀疜膉痘 瘿삨ՂᾰƌՂĀ 㺣痖帉痖Ѐ瑖堘𢡄빢᎒ՂĀ鑸᎒彿堙奋堙巫堙᎒ﻺ᎒彿堙ﻮ᎒塚堙ﻺ᎒ꍈ堞빢᎒學堙漸堞圔堙빢᎒圞堙圭堙𢡄玚Wᾰƌ ᾰƌ

23418523 25077897 29717218 27834954
Growth inhibition assay
Cell viability ; 

PubMed: 23418523     


A. Ganetespib reduced viability. Cells were treated with varying amounts of ganetespib for 72 h and subjected to MTS assay. Data are expressed as mean±SD of three independent experiments. B. Mutational status and ganetespib IC50 of cell lines.

23418523
体内研究 Ganetespib给药导致几种肿瘤异种移植模型的小鼠体内肿瘤显著缩减,且似乎毒性较低。此外,与tanespimycin相比,Ganetespib具有更好的肿瘤渗透性。[2]在恶性肥大细胞和OSA异种移植模型中,Ganetespib抑制体内肿瘤生长。 Ganetespib(25 mg/kg/day,3天)重复两个周期显著抑制肿瘤生长,%T/C值为18。Ganetespib能够被很好的耐受,载体对照和Ganetespib组相对于研究开始时的平均体重改变在第17天使分别为+0.3% 和-8.1%。[4]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

细胞实验:[1]
- 合并
  • Cell lines: OSA细胞
  • Concentrations: 0.001-1μM
  • Incubation Time: 5天
  • Method: 将1.5 × 103 OSA细胞接种于96孔板,在包含10%血清的完全培养基中培养过夜,以测定50%抑制浓度。板在第5天采集,随后用0.001,0.005,0.01,0.05,0.1,0.5和1 μM Ganetespib处理并分析。荧光测量使用酶标仪在485 nm激发波长和530 nm发射检测波长下进行。相对细胞数以对照孔的百分比计算:样品吸光度/DMSO处理的细胞吸光度× 100。
    (Only for Reference)
动物实验:[4]
- 合并
  • Animal Models: 雌性严重的联合免疫缺陷(SCID)小鼠
  • Dosages: 25 mg/kg/day,持续 3 天
  • Administration: 尾部静脉注射
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 40 mg/mL (109.76 mM)
Water Insoluble
Ethanol Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
5% DMSO+45% PEG 300+ddH2O
11mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 364.4
化学式

C20H20N4O3

CAS号 888216-25-9
储存条件 粉状
溶于溶剂
别名 N/A

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02192541 Terminated Drug: Ziv-Aflibercept|Drug: Ganetespib Neoplasms National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) December 2 2014 Phase 1
NCT02008877 Completed Drug: ganetespib|Drug: Sirolimus Malignant Peripheral Nerve Sheath Tumors (MPNST)|Sarcoma Sarcoma Alliance for Research through Collaboration|Synta Pharmaceuticals Corp.|United States Department of Defense December 2013 Phase 1|Phase 2

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1:

    Does this inhibitor inhibit both isoforms of HSP90?

  • 回答:

    We don't have the information now and it is not very clear in the literature either. From following two references, it indicates that Ganetespib might be specific to the alpha form “Ganetespib binds to the ATP binding site of Hsp90 alpha with a Kd of 110 nM” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477583/

HSP (HSP90) Signaling Pathway Map

HSP (HSP90) Inhibitors with Unique Features

相关HSP (HSP90)产品

Tags: 购买Ganetespib (STA-9090) | Ganetespib (STA-9090)供应商 | 采购Ganetespib (STA-9090) | Ganetespib (STA-9090)价格 | Ganetespib (STA-9090)生产 | 订购Ganetespib (STA-9090) | Ganetespib (STA-9090)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID